<DOC>
	<DOCNO>NCT02396004</DOCNO>
	<brief_summary>Aim study : To conduct observational study collect cerebral renal perfusion data NIRS treatment PDA medication PDA ligation . The data post treatment would form basis normative baseline data VLBW preterm newborn baby , particularly Asian population . Study population/inclusion criterion : VLBW newborn baby hemodynamically significant PDA echocardiography . Exclusion criterion : Major malformation Moribund patient</brief_summary>
	<brief_title>NIRS PDA VLBW Infants</brief_title>
	<detailed_description>Aim study : To conduct observational study collect cerebral renal perfusion data NIRS treatment PDA medication PDA ligation . The data post treatment would form basis normative baseline data VLBW preterm newborn baby , particularly Asian population . Study population/inclusion criterion : VLBW newborn baby hemodynamically significant PDA echocardiography . Exclusion criterion : Major malformation Moribund patient Protocol : Consent obtain parent eligible newborn treatment hemodynamic significant PDA . To attach cerebral renal oximeter NIRS VLBW infant PDAs 24 hour post closure PDA . Doppler ultrasound perform anterior cerebral artery ( ACA ) and/or middle cerebral artery ( MCA ) artery and/or renal artery ( RA ) PDA treatment and/or 24hours PDA closure.This study aim use one popular neonatal/paediatrics NIRS machine , INVOS cerebral/somatic oximeter The patient hence form control treatment . Echocardiographic follow-up clinical assessment closure PDA perform 24-48 hour course medication surgical closure .</detailed_description>
	<criteria>VLBW infant hemodynamically significant PDA echocardiography Major malformation Moribund</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>